ABBV : AbbVie stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-01-27 |
|---|---|---|---|---|
| 2022 | $129.73 | $119.99 | $137.19 | -4.59% |
| 2023 | $115.39 | $106.32 | $120.78 | -15.14% |
| 2024 | $104.01 | $101.97 | $105.84 | -23.5% |
| 2025 | $103.55 | $101.16 | $111.0 | -23.85% |
| 2026 | $119.23 | $113.82 | $122.64 | -12.31% |
| 2027 | $106.05 | $101.61 | $110.43 | -22.01% |
| 2028 | $104.97 | $103.91 | $107.19 | -22.8% |
| 2029 | $119.95 | $108.63 | $125.59 | -11.78% |
| 2030 | $120.94 | $109.36 | $126.88 | -11.06% |
| 2031 | $110.25 | $105.15 | $113.53 | -18.91% |
| 2032 | $104.65 | $104.65 | $104.65 | -23.04% |
The 9 Wall Street analysts offering AbbVie stock forecast in the last 6 months have average price target of
$139.0 with a high forecast of $172.0 and a low forecast of $113.0.
The average AbbVie stock forecast represents a 2.23%
increase from the last price of $135.970001220703.
From AI system, total return is 3138.37% from 3070 forecasts.
For AbbVie stock forecast for 2022, 11 predictions are offered for each month of 2022 with average AbbVie stock
forecast of $129.73, a high forecast of $137.19, and a low forecast of $119.99.
The average AbbVie stock forecast 2022 represents a -4.59%
decrease from the last price of $135.970001220703.
For AbbVie stock forecast for 2023, 12 predictions are offered for each month of 2023 with average AbbVie stock
forecast of $115.39, a high forecast of $120.78, and a low forecast of $106.32.
The average AbbVie stock forecast 2023 represents a -15.14%
decrease from the last price of $135.970001220703.
For AbbVie stock forecast for 2025, 12 predictions are offered for each month of 2025 with average AbbVie stock
forecast of $103.55, a high forecast of $111.0, and a low forecast of $101.16.
The average AbbVie stock forecast 2025 represents a -23.85%
decrease from the last price of $135.970001220703.
For AbbVie stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average AbbVie stock
forecast of $106.05, a high forecast of $110.43, and a low forecast of $101.61.
The average AbbVie stock forecast 2027 represents a -22.01%
decrease from the last price of $135.970001220703.
For AbbVie stock forecast for 2030, 12 predictions are offered for each month of 2030 with average AbbVie stock
forecast of $120.94, a high forecast of $126.88, and a low forecast of $109.36.
The average AbbVie stock forecast 2030 represents a -11.06%
decrease from the last price of $135.970001220703.
For AbbVie stock forecast for 2032 (10 year), 1 predictions are offered for each month of 2032 with average AbbVie stock
forecast of $104.65, a high forecast of $104.65, and a low forecast of $104.65.
The average AbbVie stock forecast 2032 represents a -23.04%
decrease from the last price of $135.970001220703.
Please, see more forecasts below.
ABBV : AbbVie stock forecast by Wall Street Analysts
The average AbbVie stock forecast from last 6 month is $139.0, and this show a 1.78% increase in average from the prior price target of the each prediction. Also, this average forecast of $139.0 represents a 5.1% increase from the past average forecast of $132.25, 6 months ago from 4 wall street analysts.
AbbVie stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-01-31 | $137.12 | 0.85% |
| 2022-02-01 | $137.81 | 0.50% |
| 2022-02-02 | $138.98 | 0.85% |
| 2022-02-03 | $136.66 | -1.67% |
| 2022-02-04 | $136.94 | 0.21% |
ABBV : Long term AbbVie stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Feb. is $136.58 , for 2023 Jan. is $120.78 , for 2026 Jan. is $114.10 , for 2027 Jan. is $110.43 , for 2031 Jan. is $110.57 , and for 2032 Jan. is $104.65.
ABBV : AbbVie stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Feb. | $136.58 | 0.45% |
| 2022 Mar. | $137.19 | 0.45% |
| 2022 Apr. | $137.09 | -0.08% |
| 2022 May. | $136.45 | -0.47% |
| 2022 Jun. | $134.89 | -1.14% |
| 2022 Jul. | $132.04 | -2.12% |
| 2022 Aug. | $127.98 | -3.08% |
| 2022 Sep. | $123.62 | -3.40% |
| 2022 Oct. | $120.80 | -2.28% |
| 2022 Nov. | $119.99 | -0.67% |
| 2022 Dec. | $120.40 | 0.34% |
ABBV : AbbVie stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $120.78 | 0.32% |
| 2023 Feb. | $120.65 | -0.11% |
| 2023 Mar. | $120.19 | -0.38% |
| 2023 Apr. | $119.54 | -0.54% |
| 2023 May. | $118.89 | -0.55% |
| 2023 Jun. | $118.27 | -0.52% |
| 2023 Jul. | $117.09 | -1.00% |
| 2023 Aug. | $114.76 | -1.99% |
| 2023 Sep. | $111.79 | -2.58% |
| 2023 Oct. | $109.10 | -2.41% |
| 2023 Nov. | $107.26 | -1.68% |
| 2023 Dec. | $106.32 | -0.88% |
ABBV : AbbVie stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $105.84 | -0.45% |
| 2024 Feb. | $105.57 | -0.26% |
| 2024 Mar. | $105.34 | -0.21% |
| 2024 Apr. | $105.09 | -0.24% |
| 2024 May. | $104.77 | -0.30% |
| 2024 Jun. | $104.35 | -0.41% |
| 2024 Jul. | $103.80 | -0.52% |
| 2024 Aug. | $103.28 | -0.50% |
| 2024 Sep. | $103.02 | -0.25% |
| 2024 Oct. | $102.80 | -0.22% |
| 2024 Nov. | $102.33 | -0.46% |
| 2024 Dec. | $101.97 | -0.36% |
ABBV : AbbVie stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $101.61 | -0.35% |
| 2025 Feb. | $101.31 | -0.30% |
| 2025 Mar. | $101.16 | -0.14% |
| 2025 Apr. | $101.19 | 0.02% |
| 2025 May. | $101.40 | 0.21% |
| 2025 Jun. | $101.78 | 0.37% |
| 2025 Jul. | $102.28 | 0.49% |
| 2025 Aug. | $102.87 | 0.58% |
| 2025 Sep. | $103.99 | 1.09% |
| 2025 Oct. | $105.79 | 1.73% |
| 2025 Nov. | $108.17 | 2.24% |
| 2025 Dec. | $111.00 | 2.62% |
ABBV : AbbVie stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $114.10 | 2.80% |
| 2026 Feb. | $117.21 | 2.73% |
| 2026 Mar. | $119.89 | 2.28% |
| 2026 Apr. | $121.70 | 1.51% |
| 2026 May. | $122.58 | 0.72% |
| 2026 Jun. | $122.64 | 0.06% |
| 2026 Jul. | $122.18 | -0.38% |
| 2026 Aug. | $121.33 | -0.70% |
| 2026 Sep. | $120.15 | -0.98% |
| 2026 Oct. | $118.59 | -1.30% |
| 2026 Nov. | $116.53 | -1.74% |
| 2026 Dec. | $113.82 | -2.33% |
ABBV : AbbVie stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $110.43 | -2.97% |
| 2027 Feb. | $106.66 | -3.42% |
| 2027 Mar. | $103.29 | -3.16% |
| 2027 Apr. | $101.61 | -1.62% |
| 2027 May. | $102.04 | 0.42% |
| 2027 Jun. | $104.06 | 1.98% |
| 2027 Jul. | $106.63 | 2.47% |
| 2027 Aug. | $108.33 | 1.59% |
| 2027 Sep. | $108.60 | 0.25% |
| 2027 Oct. | $107.90 | -0.65% |
| 2027 Nov. | $106.92 | -0.91% |
| 2027 Dec. | $106.07 | -0.79% |
ABBV : AbbVie stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $105.44 | -0.59% |
| 2028 Feb. | $104.97 | -0.45% |
| 2028 Mar. | $104.55 | -0.40% |
| 2028 Apr. | $104.17 | -0.36% |
| 2028 May. | $103.92 | -0.24% |
| 2028 Jun. | $103.91 | -0.01% |
| 2028 Jul. | $104.14 | 0.22% |
| 2028 Aug. | $104.55 | 0.39% |
| 2028 Sep. | $105.03 | 0.46% |
| 2028 Oct. | $105.56 | 0.50% |
| 2028 Nov. | $106.22 | 0.63% |
| 2028 Dec. | $107.19 | 0.91% |
ABBV : AbbVie stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $108.63 | 1.34% |
| 2029 Feb. | $110.65 | 1.86% |
| 2029 Mar. | $113.21 | 2.31% |
| 2029 Apr. | $116.07 | 2.52% |
| 2029 May. | $118.89 | 2.43% |
| 2029 Jun. | $121.46 | 2.17% |
| 2029 Jul. | $123.51 | 1.69% |
| 2029 Aug. | $124.83 | 1.06% |
| 2029 Sep. | $125.45 | 0.50% |
| 2029 Oct. | $125.59 | 0.11% |
| 2029 Nov. | $125.54 | -0.04% |
| 2029 Dec. | $125.58 | 0.03% |
ABBV : AbbVie stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $125.82 | 0.19% |
| 2030 Feb. | $126.24 | 0.34% |
| 2030 Mar. | $126.69 | 0.36% |
| 2030 Apr. | $126.88 | 0.16% |
| 2030 May. | $126.61 | -0.21% |
| 2030 Jun. | $125.68 | -0.74% |
| 2030 Jul. | $123.82 | -1.48% |
| 2030 Aug. | $120.82 | -2.42% |
| 2030 Sep. | $116.80 | -3.33% |
| 2030 Oct. | $112.66 | -3.55% |
| 2030 Nov. | $109.84 | -2.50% |
| 2030 Dec. | $109.36 | -0.44% |
ABBV : AbbVie stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $110.57 | 1.11% |
| 2031 Feb. | $112.18 | 1.45% |
| 2031 Mar. | $113.25 | 0.96% |
| 2031 Apr. | $113.53 | 0.25% |
| 2031 May. | $113.23 | -0.26% |
| 2031 Jun. | $112.57 | -0.59% |
| 2031 Jul. | $111.45 | -0.99% |
| 2031 Aug. | $109.93 | -1.37% |
| 2031 Sep. | $108.32 | -1.46% |
| 2031 Oct. | $106.95 | -1.27% |
| 2031 Nov. | $105.91 | -0.98% |
| 2031 Dec. | $105.15 | -0.71% |
ABBV : AbbVie stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $104.65 | -0.48% |
Financial Data for AbbVie stock
Frequently Asked Questions about AbbVie stock forecast
Is AbbVie a good long term stock?
From AbbVie stock forecast , AbbVie (ABBV) stock can be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2022 Feb. is $136.577799868973 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2023 Jan. is $120.783699766737 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2026 Jan. is $114.101958655938 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2027 Jan. is $110.433504884387 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2031 Jan. is $110.572492582687 From AbbVie stock forecast , AbbVie (ABBV) stock cannot be a good investment choice. According to AI Pickup, the AbbVie stock price forecast for 2032 Jan. is $104.646863680614
Is AbbVie stock overvalued?
AbbVie (ABBV) stock is expected to go DOWN . Therefore, AI Pickup would say that AbbVie (ABBV) stock is overvalued.
Will AbbVie stock price go up?
No. The AbbVie stock price forecast for 2023 Jan. is $120.783699766737
Is AbbVie stock a good buy now?
Since closing price on 2022-01-27 is $135.970001220703 and forecast for 2023 Jan. is $120.78, AbbVie stock is not a good 1 year investment.